|
- Latest Research Findings and Development in Asian Eye Diseases
Singapore Eye Research Institute (SERI), a
wholly owned subsidiary of the Singapore National Eye Centre (SNEC),
and the national coordinating centre for ophthalmic and vision-related
biomedical research in Singapore, is honoured to host the First
SERI-ARVO Meeting on Vision and Ophthalmology to be held from 6-9
February 2003 at the Suntec Singapore International Convention &
Exhibition Centre.
More than 600 speakers and delegates from 37
countries will converge in Singapore next week to participate in
this major international eye research meeting, which is organised
with the strong support of the American Association of Research
in Vision and Ophthalmology (ARVO). The ARVO meeting is the foremost
eye research meeting in the world, and has traditionally been held
in Florida, USA, for over 4 decades. This is the first time that
ARVO is sponsoring a scientific meeting outside the USA.
The international research community can look
forward to 4 days of comprehensive programme featuring Keynote Lectures,
Symposia on Myopia and Physiological Optics, Glaucoma, Cornea &
Refractive Surgery, Retina, Ocular Epidemiology & International
Ophthalmology, Stem Cell Biology, Genetics and Ocular Inflammation.
Local researchers will present their results of eye stem cell culture
and transplants, and our clinical drug trials to retard myopia progression
in Singapore schoolchildren will also be highlighted at the meeting.
Recognising the importance of training the next generation of researchers
to propel ophthalmic development, the meeting has also included
a series of workshops on Understanding Basic Science Research, How
To Design and Conduct Clinical Research and How to Write a Successful
Grant and Scientific Paper.
Dr Tony Tan, Deputy Prime Minister and Minister
for Defence will be the Guest-of-Honour at the Opening Ceremony
on Friday, 7 February 2003.
| Press Statement by |
: |
Public Relations Department, SNEC
for Singapore Eye Research Institute |
| Date |
: |
29 January 2003 |
|